ClinicalTrials.gg
CompletedNCT07778875CRC-HBMUpdated Sep 4, 2026

Self-Reported Colorectal Cancer Screening Uptake

An interventional study of Health Belief Model-Based Colorectal Cancer Education Program in Colorectal Cancer Control and Prevention, sponsored by Bartın Unıversity. Completed at 1 site in Turkey (Türkiye). Open to participants aged 50 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-04.

Sponsored by Bartın Unıversity · Not applicable, Interventional, and Screening

From the registry’s dates

  • Registered 1 year 5 months after the study started (first participant enrolled Mar 2025, registered Aug 2026).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
176
Allocation
Randomized
Ages
50 Years to 70 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-14

Among 85 studies in Health Education with a site in Turkey — 10 open to participants now, 16 under way, none of them phase 3. Health Education · Turkey.

Enrollment
12th of 79
176 · median 100
Started
2025
with 20 others
No phase
79 of 85
10 open now
Registered
80th of 85
by date

Among the 85 studies in Health Education with a site in Turkey, this one is the 12th largest by enrollment of the 79 interventional ones that give a count, is one of 21 that started in 2025, is one of 79 with no phase, and was the 80th registered.

Health Education

483 studies on the registry are indexed under Health Education; 112 are open to participants now.

Browse Health Education studies →

Open to participants now

10 of the 85 studies in Health Education with a site in Turkey are open now. Recruiting first, the newest first:

5 more — sign in →

All 10 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 46 Health Education studies recruiting now, 29 (63%) set no upper age limit and 14 (30%) stop at 75 or younger; 11 take children under 18; 18 take healthy volunteers.

This study: 50 Years to 70 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 85 studies in Health Education with a site in Turkey, or all of them as a file.
02

Study summary

This randomized controlled trial evaluated the effect of a Health Belief Model-based multicomponent education program on colorectal cancer screening completion, knowledge, health beliefs, and screening attitudes among adults aged 50-70 years. A total of 176 participants were randomly assigned to an intervention group or a control group. The intervention group received an individual 30-35-minute face-to-face education session supported by a video and an informational brochure. The control group received no structured colorectal cancer education during the four-week study period and was offered the brochure after completing the Week 4 assessment. Colorectal cancer knowledge, health beliefs, and screening attitudes were assessed at baseline and Week 4. Self-reported screening completion during the follow-up period was assessed at Week 4. It was hypothesized that participants receiving the program would demonstrate greater improvements in colorectal cancer-related knowledge, health beliefs, screening attitudes, and screening uptake than participants in the control group.

Read the detailed description

This two-arm, parallel-group rrandomized controlled trial was conducted at Bartın Healthy Living Center in Bartın, Türkiye. Community-dwelling adults aged 50-70 years were assigned to the intervention or control group using simple randomization.

The intervention group received an individual educational program developed according to the Health Belief Model. The program combined face-to-face education, video-based education, and an informational brochure. It addressed colorectal cancer risk factors, symptoms, prevention, recommended screening methods, and the importance of early detection. The educational content was structured to address perceived susceptibility, perceived severity, perceived benefits, perceived barriers, health motivation, and confidence in engaging in screening behavior.

03

Conditions studied

  • Colorectal Cancer Control and Prevention

Browse trials for

Keywords

  • Colorectal Cancer Screening
  • Health Belief Model
  • Health Education
  • Cancer Screening Attitudes
  • Screening Behavior
  • Fecal Occult Blood Test
04

Who can participate

Ages eligible
50 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Aged 50-70 years
  • Residing in Bartın city center
  • No history of colorectal cancer
  • Willing to participate in the study
  • Provided written

Exclusion criteria

Exclusion Criteria:

  • Previous diagnosis of or treatment for colorectal cancer
  • Communication difficulties that prevented completion of the questionnaires
  • Cognitive impairment that prevented completion of the questionnaires
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Screening
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
176 participants (actual)

Study arms

  • Experimental
    Health Belief Model-Based Education

    Participants received an individual Health Belief Model-based colorectal cancer education program combining face-to-face education, video-based educational content, and an informational brochure. Colorectal cancer knowledge, health beliefs, and attitudes toward cancer screening were assessed at baseline and week 4. Self-reported colorectal cancer screening uptake during the four-week follow-up period was assessed at week 4.

    Behavioral: Health Belief Model-Based Colorectal Cancer Education Program

  • No intervention
    Control Group

    Participants received no structured face-to-face or video-based colorectal cancer education during the four-week study period. Colorectal cancer knowledge, health beliefs, and attitudes toward cancer screening were assessed at baseline and Week 4. Self-reported colorectal cancer screening uptake during the four-week follow-up period was assessed at Week 4. After all week 4 assessments had been completed, participants received the informational brochure.

Interventions

  • BehavioralHealth Belief Model-Based Colorectal Cancer Education Program

    The individual educational program combined face-to-face instruction, video-based educational content, and an informational brochure. It addressed colorectal cancer risk factors, symptoms, prevention, early detection, recommended screening methods, health beliefs, and participation in colorectal cancer screening.

06

What researchers measure

Primary outcomes

  1. Self-Reported Colorectal Cancer Screening Uptake

    The number and proportion of participants who self-reported completing at least one colorectal cancer screening test during the four-week follow-up period were assessed. Screening included fecal occult blood testing or colonoscopy.

    Time frame: 4 weeks after the intervention

Secondary outcomes

  1. Change From Baseline in Colorectal Cancer Knowledge Score

    Colorectal cancer knowledge was assessed using the knowledge section of the Colorectal Cancer Early Detection Knowledge and Screening Practices Form. Scores range from 0 to 18, with higher scores indicating greater knowledge of colorectal cancer risk factors, symptoms, screening methods, and the recommended screening age.

    Time frame: Baseline and 4 weeks after the intervention

  2. Change From Baseline in Perceived Confidence and Benefits Score

    Perceived confidence and benefits were assessed using the 11-item confidence/benefits subscale of the Colorectal Cancer Health Belief Model Scale. Raw total scores range from 11 to 55. For analysis, the total score was divided by 11 to obtain a mean item score ranging from 1 to 5. Higher scores indicate greater confidence in and perceived benefits of colorectal cancer screening.

    Time frame: Baseline and 4 weeks after the intervention

  3. Change From Baseline in Perceived Barriers Score

    Perceived barriers to colorectal cancer screening were assessed using the six-item perceived barriers subscale of the Colorectal Cancer Health Belief Model Scale. Raw total scores range from 6 to 30. For analysis, the total score was divided by six to obtain a mean item score ranging from 1 to 5. Higher scores indicate greater perceived barriers to colorectal cancer screening.

    Time frame: Baseline and 4 weeks after the intervention

  4. Change From Baseline in Health Motivation Score

    Health motivation was assessed using the five-item health motivation subscale of the Colorectal Cancer Health Belief Model Scale. Raw total scores range from 5 to 25. For analysis, the total score was divided by five to obtain a mean item score ranging from 1 to 5. Higher scores indicate greater health motivation.

    Time frame: Baseline and 4 weeks after the intervention

  5. Change From Baseline in Perceived Susceptibility Score

    Perceived susceptibility was assessed using the six-item perceived susceptibility subscale of the Colorectal Cancer Health Belief Model Scale. Raw total scores range from 6 to 30. For analysis, the total score was divided by six to obtain a mean item score ranging from 1 to 5. Higher scores indicate greater perceived susceptibility to colorectal cancer.

    Time frame: Baseline and 4 weeks after the intervention

  6. Change From Baseline in Perceived Severity Score

    Perceived severity was assessed using the five-item perceived severity subscale of the Colorectal Cancer Health Belief Model Scale. Raw total scores range from 5 to 25. For analysis, the total score was divided by five to obtain a mean item score ranging from 1 to 5. Higher scores indicate greater perceived severity of colorectal cancer.

    Time frame: Baseline and 4 weeks after the intervention

  7. Change From Baseline in Attitudes Toward Cancer Screening Score

    Attitudes toward cancer screening were assessed using the 24-item Attitudes Toward Cancer Screening Scale. Raw total scores range from 24 to 120. For analysis, the total score was divided by 24 to obtain a mean item score ranging from 1 to 5. Higher scores indicate more positive attitudes toward cancer screening.

    Time frame: Baseline and 4 weeks after the intervention

07

Study locations

1 site
  • Bartın Yaşam Merkezi
    Bartın, Merkez 74100, Turkey (Türkiye)
08

References and documents

Individual participant data

Plan to share: No — No individual participant data sharing plan was established in the original study protocol

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Mar 2025 to primary completion in May 2025, 2 months.

Of 292 non-industry interventional studies with no phase under Health Education, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 3 and three quarters within 24. This study's 2 months is below that.

Counting every sponsor, half of 293 studies reached it within 11 months; a quarter within 3 and three quarters within 24.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 18, 2026
First posted
Aug 21, 2026
StartActual
Mar 10, 2025
Primary completionActual
May 23, 2025
CompletionActual
May 23, 2025
Last update
Sep 4, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 4, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07778875
Lead sponsor
Bartın Unıversity
Responsible party
Ayfer Bayındır Çevik (Professor, Department of Nursing, Faculty of Health Sciences, Bartın Unıversity) — Principal investigator
First posted
Aug 21, 2026
Start date
Mar 10, 2025
Primary completion
May 23, 2025
Completion
May 23, 2025
Last update
Sep 4, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion